GRP
EDIT icon

Global Retirement Partners’s Editas Medicine EDIT Stock Holding History

Global Retirement Partners’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-200
Closed -$682 – 3684
2024
Q3 		$682 Sell
200
-600
-75% -$2.61K ﹤0.01% 3228
2024
Q2 		$3.74K Buy
800
+400
+100% +$2.26K ﹤0.01% 2738
2024
Q1 		$2.97K Hold
400
– – ﹤0.01% 2592
2023
Q4 		$3.53K Buy
+400
New +$3.51K ﹤0.01% 2464
2019
Q3 		– Sell
-69
Closed -$2K – 1617
2019
Q2 		$2K Buy
+69
New +$1.65K ﹤0.01% 1433

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Global Retirement Partners's EDIT Position: Q4 2024 in Review

Global Retirement Partners sold out of Editas Medicine (EDIT) in Q4 2024, closing a stake of 200 shares — an estimated $682 sold.

Global Retirement Partners first reported a position in EDIT in Q2 2019 and held it in 5 quarters. The position peaked at $3.74K in Q2 2024. 206 funds tracked by Wall St. Rank hold EDIT as of Q4 2024.

  • Global Retirement Partners reported no remaining Editas Medicine position as of Q4 2024 after selling out during the quarter.
  • Global Retirement Partners sold 200 Editas Medicine shares in Q4 2024, an estimated $682.
  • Global Retirement Partners first reported a position in Editas Medicine in Q2 2019 and held it in 5 quarters.
  • Global Retirement Partners's Editas Medicine position peaked at $3.74K in Q2 2024.
  • 206 funds tracked by Wall St. Rank held Editas Medicine as of Q4 2024.

Based on Global Retirement Partners's 13F filing for Q4 2024, filed 31 Jan 2025.